Barclays PLC Cv Rx, Inc. Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Barclays PLC holds 19,067 shares of CVRX stock, worth $283,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,067
Previous 19,067
-0.0%
Holding current value
$283,144
Previous $169,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$60.9 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$35.2 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$12.2 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$10.1 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $306M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...